F2 Bioscience I 2017 Ltd

Other

US·SEC (Form 4)

Cullinan Oncology, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€270,520

▼ Sales (1 ops.)

Browse the full record of transactions filed by F2 Bioscience I 2017 Ltd. Officer active across 1 companies, notably Cullinan Oncology, Inc.. Aggregated, 1 disclosures have been published. Total volume traded: €271k. The latest transaction was disclosed on 21 June 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.

Declarations1 total

Executives▼SaleCCullinan Oncology, Inc.22SEC

F

F2 Bioscience I 2017 Ltd

€270,52022,319 shares@ €12.12060.028% mcap100.0% of flow

Common Stock

SEC:0001104659-22-073980:0·21 Jun 2022

SEC ↗

1 of 1 declaration